Pacira Biosciences Inc
NASDAQ:PCRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
|
Panasonic Holdings Corp
TSE:6752
|
JP |
|
L
|
LTC Properties Inc
LSE:0JSP
|
US |
|
D
|
DSV A/S
DUS:DS81
|
DK |
|
SSR Mining Inc
NASDAQ:SSRM
|
CA |
|
P
|
Procter & Gamble Co
BMV:PG
|
US |
|
L
|
Live Nation Entertainment Inc
F:3LN
|
US |
|
Gold Fields Ltd
F:EDG
|
ZA |
|
A
|
Apple Inc
XHAM:APC
|
US |
|
R
|
Relx PLC
F:RDEB
|
UK |
|
B
|
Bayerische Motoren Werke AG
LSE:0O0U
|
DE |
|
DBV Technologies SA
F:DBV1
|
FR |
|
M
|
Monster Beverage Corp
BMV:MNST
|
US |
|
Sumber Alfaria Trijaya Tbk PT
IDX:AMRT
|
ID |
|
A
|
ASML Holding NV
F:ASME
|
NL |
|
S
|
State Street Corp
SWB:ZYA
|
US |
|
L
|
Lloyds Banking Group PLC
XETRA:LLD
|
UK |
|
A
|
Advanced Energy Industries Inc
XBER:AVX
|
US |
|
C
|
CVS Health Corp
XBER:CVS
|
US |
|
B
|
Baxter International Inc
BMV:BAX
|
US |
|
H
|
Hecla Mining Co
DUS:HCL
|
US |
|
S
|
Stepan Co
F:96S
|
US |
|
J
|
Jabil Inc
SWB:JBL
|
US |
|
L
|
Luk Fook Holdings (International) Ltd
SWB:LUY1
|
HK |
Wall St Price Targets
PCRX Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for PCRX is 29.29 USD with a low forecast of 22.22 USD and a high forecast of 39.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCRX's stock price target?
Price Target
29.29
USD
According to Wall Street analysts, the average 1-year price target for PCRX is 29.29 USD with a low forecast of 22.22 USD and a high forecast of 39.9 USD.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 0%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
49%
The compound annual growth rate for Operating Income over the next 5 years is 49%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
58%
The compound annual growth rate for Net Income over the next 7 years is 58%.
